CLINICAL MEDICAL DIAGNOSTIC APPLICATIONS FOR ADVANCED MICROLABS TECHNOLOGY

Since 2004, Advanced MicroLabs has completed the request cycle for eight NSF or NIH grants and received five awards.  The successful grants are to develop and refine measurement techniques for:

Glycated Hemoglobin – a preferred blood chemistry marker for monitoring diabetes.  Glycated Hemoglobin (HbA1C or A1C) is an important measure of diabetic health and is more accurate than glucose measurements to follow long-term regulation of the disease. 
        Phase I and Phase II SBIR Grants.
        Supported by NSF SBIR Program Award #0419441 & #0548744

Creatinine  – a kidney function marker that is effective in diagnosing End Stage Renal Disease.
        Phase I SBIR Grant.
        Supported by NIH SBIR Program Award #1R43DK072622-01A1

Homocysteine – a blood marker with growing acceptance as an indicator of cardiac disease. 
        Phase I SBIR and Phase II Grant.
        Supported by NIH SBIR Program Award #1R43HL083579-01 & 2R44HL083579-02

Each of these research efforts individually developed the fundamental chemistry for the measurement and collectively contributed to the development of MicroChip manufacturability and instrument integration.  These efforts are currently on hold since there is greater customer pull for contamination measurements in water.

  Home   Company   Technology   Applications   Contact   Press   Partners